Engineers Gate Manager’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,540
Closed -$110K 2463
2025
Q2
$110K Sell
13,540
-34,738
-72% -$297K ﹤0.01% 1981
2025
Q1
$379K Buy
48,278
+32,536
+207% +$377K 0.01% 1575
2024
Q4
$234K Sell
15,742
-8,047
-34% -$131K ﹤0.01% 1829
2024
Q3
$364K Sell
23,789
-5,203
-18% -$82K 0.01% 1539
2024
Q2
$442K Buy
+28,992
New +$468K 0.01% 1277
2023
Q4
Sell
-20,704
Closed -$372K 2193
2023
Q3
$372K Buy
+20,704
New +$416K 0.01% 1220
2023
Q1
Sell
-57,666
Closed -$1.19M 1942
2022
Q4
$1.19M Buy
57,666
+49,197
+581% +$1.35M 0.07% 387
2022
Q3
$222K Sell
8,469
-9,221
-52% -$244K 0.01% 1274
2022
Q2
$448K Sell
17,690
-5,677
-24% -$139K 0.02% 1173
2022
Q1
$737K Buy
+23,367
New +$783K 0.03% 851
2021
Q1
Sell
-14,110
Closed -$366K 2075
2020
Q4
$366K Sell
14,110
-20,641
-59% -$500K 0.02% 1168
2020
Q3
$596K Buy
+34,751
New +$776K 0.03% 893

Other funds holding RCUS

Engineers Gate Manager's RCUS Position: Q3 2025 in Review

Engineers Gate Manager sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 13,540 shares — an estimated $110K sold.

Engineers Gate Manager first reported a position in RCUS in Q3 2020 and held it in 12 quarters. The position peaked at $1.19M in Q4 2022. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

  • Engineers Gate Manager reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 13,540 Arcus Biosciences shares in Q3 2025, an estimated $110K.
  • Engineers Gate Manager first reported a position in Arcus Biosciences in Q3 2020 and held it in 12 quarters.
  • Engineers Gate Manager's Arcus Biosciences position peaked at $1.19M in Q4 2022.
  • 190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Engineers Gate Manager's 13F filing for Q3 2025, filed 14 Nov 2025.